BackAllarity Therapeutics Overview

Allarity Therapeutics Current Cash

Latest current cash for ALLR: $20M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$19.81M
↓ 21.38% YoYΔ $-5.39M vs prior year quarter

Peer average

Loading

Allarity Therapeutics Current Cash History

Loading

Allarity Therapeutics vs. peers: Current Cash Comparison

Loading

Allarity Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Allarity Therapeutics (ALLR) FAQ

Allarity Therapeutics posts a current cash of $20M as of March 2026. That compares with $25M in the prior-year period — down 21.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Allarity Therapeutics's current cash was $25M. The latest reading is $20M — a 21.4% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Allarity Therapeutics's financial statement story. At $20M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ALLR's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Allarity Therapeutics's other metric pages and overview cover the third.